Network Pharmacology and Molecular Docking–Based Investigation: Prunus mume Against Colorectal Cancer via Silencing RelA Expression
Colorectal cancer (CRC) is one of the most pervasive cancers in the human disease spectrum worldwide, ranked the second most common cause of cancer death by the end of 2020. Prunus mume (PM) is an essential traditional Chinese medicine for the adjuvant treatment of solid tumors, including CRC. In th...
Main Authors: | Minfeng Zhou, Jinxiao Li, Dan Luo, Haiming Zhang, Zhaomin Yu, Youlin Chen, Qiumeng Li, Fengxia Liang, Rui Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.761980/full |
Similar Items
-
Knockdown of RSPH14 inhibits proliferation, migration, and invasion and promotes apoptosis of hepatocellular carcinoma via RelA
by: Dawei Yuan, et al.
Published: (2022-03-01) -
De novo transcriptome assembly of two different Prunus mume cultivars
by: Yeonhwa Jo, et al.
Published: (2015-12-01) -
Intramolecular Interactions Dominate the Autoregulation of Escherichia coli Stringent Factor RelA
by: Kathryn Jane Turnbull, et al.
Published: (2019-08-01) -
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window
by: Annamaria Lanzillotta, et al.
Published: (2013-01-01) -
Ribosome•RelA structures reveal the mechanism of stringent response activation
by: Anna B Loveland, et al.
Published: (2016-07-01)